SLAS announces the cohort for innovation AveNEW startups at SLAS Europe 2026
Grant and Award Announcement
Updates every hour. Last Updated: 12-Jun-2026 20:16 ET (13-Jun-2026 00:16 GMT/UTC)
Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a spectrum of disease conditions and has an increasing prevalence worldwide. A new review highlights how elevated uric acid (UA) may actively contribute to the development and progression of the disease. Evidence suggests that UA promotes inflammation, oxidative stress, and metabolic disturbances in the liver. It may serve as a biomarker and therapeutic target for improving MASLD diagnosis and treatment.
The dedicator of cytokinesis 10 (DOCK10) gene has been identified as a key driver of abnormal insulin secretion in insulinomas, as reported by researchers from Institute of Science Tokyo. Using surgical specimens and patient-derived organoids, the team performed comprehensive genetic and transcriptomic analyses, revealing that inhibiting a DOCK10-related pathway reduced excessive insulin release in cellular and animal models. These results pave the way for novel diagnostic biomarkers and treatment options for insulinomas.
A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle-income countries, and may reduce newborn deaths.